ABG-WTT Global Life Science Capital Partners’s CeriBell Inc CBLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.36M Sell
275,328
-166,492
-38% -$3.16M 62.61% 1
2026
Q1
$8.1M Hold
441,820
65.87% 1
2025
Q4
$9.69M Sell
441,820
-646,281
-59% -$10M 64.38% 1
2025
Q3
$12.5M Hold
1,088,101
66.94% 1
2025
Q2
$20.4M Hold
1,088,101
76.17% 1
2025
Q1
$20.9M Hold
1,088,101
54.54% 1
2024
Q4
$28.2M Buy
+1,088,101
New +$29.6M 64.42% 1

Other funds holding CBLL

ABG-WTT Global Life Science Capital Partners's CBLL Position: Q2 2026 in Review

ABG-WTT Global Life Science Capital Partners reduced its CeriBell Inc (CBLL) stake by 38% in Q2 2026, selling an estimated $3.16M and leaving 275,328 shares worth $5.36M. The position accounts for 62.61% of the portfolio, ranked #1.

ABG-WTT Global Life Science Capital Partners first reported a position in CBLL in Q4 2024 and has held it in 7 quarters since. The position peaked at $28.2M in Q4 2024. 122 funds tracked by Wall St. Rank hold CBLL as of Q2 2026.

  • ABG-WTT Global Life Science Capital Partners held 275,328 shares of CeriBell Inc worth $5.36M as of Q2 2026.
  • ABG-WTT Global Life Science Capital Partners sold 166,492 CeriBell Inc shares in Q2 2026, an estimated $3.16M.
  • CeriBell Inc made up 62.61% of ABG-WTT Global Life Science Capital Partners's portfolio in Q2 2026, its #1 holding.
  • ABG-WTT Global Life Science Capital Partners first reported a position in CeriBell Inc in Q4 2024 and has held it in 7 quarters since.
  • ABG-WTT Global Life Science Capital Partners's CeriBell Inc position peaked at $28.2M in Q4 2024.
  • 122 funds tracked by Wall St. Rank held CeriBell Inc as of Q2 2026.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.